Lipid-Lowering Treatment in Coronary Artery Disease: How Low Should Cholesterol Go?

ISSN： 0012-6667

Source： Drugs, Vol.59, Iss.5, 2000-05, pp. : 1127-1135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antihypertensive therapy in stroke: how low should you go?

Inpharma, Vol. 1, Iss. 1230, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

How Well Tolerated Are Lipid-Lowering Drugs?

By Tomlinson B.

Drugs & Aging, Vol. 18, Iss. 9, 2001-01 ,pp. : 665-683

Adis International

Access to resources Recommend Favorite

Intensive lipid-lowering therapy in coronary artery disease: implications of the REVERSAL and PROVE-IT trials

By Salam Amar M

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 6, 2004-06 ,pp. : 707-713

Informa Healthcare

Access to resources Recommend Favorite

Progress in Colorectal Cancer Chemotherapy: How Far Have We Come, How Far to Go?

By Royce M.E.

Drugs & Aging, Vol. 17, Iss. 3, 2000-09 ,pp. : 201-216

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US

By Rosen Virginia M.

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 47-60

Adis International

Access to resources Recommend Favorite